MiniMed Announces 71% Increase in Profit
MiniMed Inc., a Sylmar company that makes portable insulin pumps for people with diabetes, said its profit for the third quarter that ended Sept. 30 was $703,000, up 71% from $410,000 last year. Sales for the third quarter were up 12% to $11 million from $9.8 million in the third quarter last year.
For the first nine months of this year, the company’s profit was $352,000 compared to a loss of $1.03 million last year. Year-to-date sales were up 21% to $30.3 million from $25 million at this time last year.
The company attributed its increased sales for the quarter and the year-to-date turnaround to growing acceptance of its products, which offer some diabetes patients alternatives to daily injections of insulin.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.